R Chou, M Helfand - Annals of internal medicine, 2005 - Am Coll Physicians An evidence synthesis of a medical intervention should assess the balance of
benefits and harms. Investigators performing systematic reviews of harms face
challenges in finding data, rating the quality of harms reporting, and ... Cited by 45 - Related articles - All 4 versions
- ►annals.org L Hartling, FA McAlister, BH Rowe, J … - Annals of internal medicine, 2005 - Am Coll Physicians The authors discuss 3 challenges in conducting and interpreting any systematic
review that are particularly relevant for systematic reviews of therapeutic
devices or surgical procedures: 1) inclusion or exclusion of grey ... Cited by 34 - Related articles - All 4 versions
- ►cancer.gov [PDF] JF Kerner, J Guirguis-Blake, KD Hennessy, PJ … - Cancer Causes and Control, 2005 - Springer Jon F. Kerner 1, *, Janelle Guirguis-Blake 2 , Kevin D. Hennessy 3 , Paul J.
Brounstein 3 , Cynthia Vinson 1 , Randy H. ... Schwartz 4 , Bradford A. Myers 5
& Peter Briss 5 1 National Cancer Institute, Bethesda, MD, USA; Cited by 25 - Related articles - BL Direct - All 6 versions
G Salanti, J Higgins, AE Ades, J Ioannidis - Statistical methods in medical research, 2008 - smm.sagepub.com Randomized trials may be designed and interpreted as single experiments or they
may be seen in the context of other similar or relevant evidence. The amount and
complexity of available randomized evidence vary for different topics. ... Cited by 21 - Related articles - All 3 versions
- ►ahajournals.org BK Nallamothu, RA Hayward, ER Bates - Circulation, 2008 - Am Heart Assoc Randomized clinical trials (RCTs) are familiar to most clinicians involved in
the care of patients with cardiovascular disease. RCTs are the uncontested "gold
standard" for establishing causation between a therapy and outcomes for a ... Cited by 6 - Related articles - All 5 versions
EP Whitlock, SA Lopez, S Chang, M Helfand, … - Journal of Clinical Epidemiology, 2009 - Elsevier A topic prioritization group representing stakeholder and scientific
perspectives evaluates topic nominations that fit within the EHC program (are
“appropriate”) to determine how “important” topics are as ... Cited by 2 - Related articles - All 2 versions
M Helfand, H Balshem - Journal of Clinical Epidemiology, 2009 - Elsevier We briefly describe the role stakeholders play in providing important insights
that inform the evidence-gathering process, and discuss the critical role of
analytic frameworks in illuminating the relationship between surrogate ... Cited by 3 - Related articles - All 2 versions
JM Gay - Theriogenology, 2006 - Elsevier With evolving technology and continual change in the client industries, whether
domestic pets or agricultural animals, new opportunities for productive
collaborations between the disciplines of theriogenology and epidemiology ... Related articles - All 12 versions
M Machado, TR Einarson - Journal of Clinical Pharmacy and Therapeutics, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
BK Nallamothu, RA Hayward, ER Bates - Circulation, 2008 - pt.wkhealth.com Randomized clinical trials (RCTs) are familiar to most clinicians involved in
the care of patients with cardio- vascular disease. RCTs are the uncontested
“gold standard” for establishing causation between a therapy and ... Related articles - All 2 versions
